Blaze Bioscience, Inc.
PrivateLast Round
VC Round
Apr 8, 2020
Total Funding Raised
$18.8M
Company Overview
Blaze Bioscience, Inc. is a biotechnology company that develops Tumor Paint technology to provide real-time, high-resolution visualization of cancer cells during surgery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Blaze Bioscience, Inc. Comparables
Compare Blaze Bioscience, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avelas Biosciences | 92% | |
| Vergent Bioscience | 92% | |
| On Target Laboratories | 89% | |
Blaze Bioscience, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 8, 2020 | ||||
| VC Round | Dec 31, 2019 | ||||
| Series B | Dec 3, 2013 | ||||
| Series A | Feb 22, 2013 | ||||
| Seed | Oct 18, 2011 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 112% MoM, reaching 4.1K.
- Jan 6, 2026
Monthly visitors grew 520% MoM, reaching 1.7K.
Blaze Bioscience, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Blaze Bioscience, Inc.'s valuation, stock price, and market status.